NCT00026884Recruiting
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Diseases
Source: ClinicalTrials.gov · Last updated 4 Nov 2026
Brief summary (registry, in English)
Selected individuals suspected of having or with prior biopsy proof of malignant disease will be seen in the Urologic Oncology Branch, NCI. Blood samples may be collected at the time of the initial visit and at periodic intervals during the course of the disease. These samples will be stored in the tissue bank of the Urologic Oncology Branch. Aliquots of malignant and normal tissue will be collected at the time of surgery and stored in the tissue bank, Urologic Oncology Branch, NCI. These materials will be used in the research efforts of the Urologic Oncology Branch, NCI.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 5950 (estimated)
- First submitted
- 14 Nov 2001
- Start date
- 12 Mar 1998
- Lead sponsor
- National Cancer Institute (NCI)
- Diseases
- Kidney cancer, Bladder cancer, Childhood cancers
- NCT number
- NCT00026884
What you commit to
- Study type: Observational
- Planned participants: 5950
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- -Individuals whose co-morbidities preclude surgical intervention.
Criteria the registry did not label
- INCLUSION CRITERIA:
- Individuals with biopsy-proven malignant disease
- Individuals suspected of having a malignant disease
- Individuals who have or are suspected of having an inherited genitourinary malignant disorder
- Participants must be \>= 2 years of age
- A relative (related by blood) of an individual with a confirmed or suspected diagnosis of a malignant disease or an inherited genitourinary malignant disorder.
- All participants and parents/guardians, for children younger than 18 years of age, must sign an informed consent document indicating their understanding of the investigational nature and the risks of this study before any protocol related studies are performed.
Age in the registry: 2 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Institutes of Health Clinical Center Coordinator of this site? Confirm its status | Bethesda | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.